MilliporeSigma is collaborating with Massachusetts Institute of Technology’s Center for Collective Intelligence and Community Biotechnology Initiative to crowdsource expertise and answers in crucial areas for pandemic response. Here, find the latest media assets and content from events, reports and ongoing initiatives.
Rapid Research and Disruptive Development
As rapid pandemic response efforts have proven over the last 18 months, accelerating tools and approaches for discovery can increase productivity.
In our second Catalyst Conversation of 2021, experts discuss mechanisms to embed and empower fast-tracked R&D across the global scientific community.
Reimagining the Global Health Ecosystem in a Post-COVID World
COVID-19 sent shockwaves throughout the Life Science ecosystem – uniting us all with a common purpose and busting through log jams that had previously hindered the speed of addressing global health challenges.
How do we identify and apply the learnings from the COVID-19 pandemic to reimagine the institutions, processes, policies and tools we use across the Life Sciences to address global health needs for all?
MilliporeSigma is collaborating with Massachusetts Institute of Technology’s Center for Collective Intelligence and Community Biotechnology Initiative to crowdsource expertise and answers in crucial areas for the future of Life Sciences. Our first Catalyst Conversation event of 2021 will focus on Reimagining the Global Health Ecosystem in a Post-COVID World.
Harnessing Data, Diligence and Collective Intelligence
Monitoring viral spread, accelerating clinical trials and delivering health equity are essential to a strong pandemic response. Former CEO Udit Batra and head of the Life Science Innovation Board Patrick Schneider joined Boston Medical Center’s Kate Walsh, Genpact’s Gianni Giacomelli and Massachusetts Institute of Technology’s David Sun Kong for a virtual discussion on the most promising ideas, crowdsourced from 180 experts around the world, to combat COVID-19.
Innovations in Diagnostics and Detection on the Road to Re-densification
Early detection of COVID-19 can enable the world’s gradual return to regular activity. Head of Diagnostic Solutions Yves Dubaquie joined Sonde Health’s Jim Harper, Biobot Analytics’ Mariana Matus and Massachusetts Institute of Technology’s David Sun Kong for a virtual discussion on testing options and developing technologies, like vocal biomarkers and sewage monitoring, that can track viral spread.
Vaccines and Therapies and the Need for Speed
The world is investing in rapid development of vaccines and therapies for COVID-19. Head of chemistry R&D Jehangir Mistry and head of process solutions services R&D Audrey Chang join independent consultant David Onions, Bill & Melinda Gates Medical Research Institute’s Jared Silverman and messagingLab’s Karl Schmieder for a virtual discussion on safe, effective strategies – like open science, unified standards and new testing methods – to accelerate clinical trials.
Validating and Sharing Scientific Information
As understanding of COVID-19 evolves, strategies to validate and communicate the latest scientific insights can help the public determine fact from fiction. Head of global communications & business markets/services Renee Connolly joins Institute for Health Metrics and Evaluation’s Vin Gupta, MIT Press’s Nick Lindsay and Massachusetts Institute of Technology’s David Sun Kong for a virtual discussion on how the role of pre-prints, data and more can help cut through the clutter and promote cohesion to combat the pandemic.
Lessons Learned on the Road to Pandemic Preparedness
How can the global scientific community help society find its way out of the current pandemic and emerge more resourceful for future public health crises? Interim CEO Chris Ross hosts as chair of the Life Science Innovation Board Patrick Schneider joins former U.S. Assistant Surgeon General and MIT Media Lab visiting professor Rear Admiral Susan J. Blumenthal, Harvard University’s Pardis Sabeti and Johns Hopkins Center for Health Security’s Amesh Adalja for a virtual discussion on lessons learned from COVID-19 and progress made to better prepare our public health systems, accelerate the scientific process and guide positive group behaviors for future pandemics.